Nova Biomedical Integrates NanoCellect Products to Enhance Cell Line Development

Nova Biomedical has announced the integration of certain assets from NanoCellect, a company specializing in microfluidic cell sorting technology. This strategic move aims to improve and streamline integrated cell line development workflows. The transaction signifies an expansion in Nova Biomedical's product offerings and operational capabilities within the biotech sector.